LUNG Pulmonx Corporation
$1.25▲ +0.00%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$52.80M
P/E Ratio
–
Div Yield
–%
52W Range
1.13 - 3.39
% vs 50 MA
-11.33%
% vs 200 MA
-22.44%
RSI-14
42.6
MACD Histogram
-0.0200
Beta (1Y vs SPY)
2.08
Gross Rev
$88.55M
Gross Profit
$66.84M
EBITDA
-$51.16M
COGS
$21.70M
Operating Exp
$118.00M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.72 · 29 posts
NewsWhy I invested $900k in IOVa
r/stocks · Jul 11, 2026
The post highlights the potential success of LUNG's clinical trial results as a significant factor in IOVA's stock price.
positive
+0.80
NewsDiscussionBNTX ASCO 2026 DD
r/wallstreetbets · May 31, 2026
Discussion of Keytruda’s market share and BioNTech's ambition to compete.
positive
+0.60
NewsDiscussionTradePriceTargetBNTX is about to go full send at ASCO and nobody’s talking about it 🚀🧬
r/wallstreetbets · May 18, 2026
The comparison to Keytruda suggests a strong potential for efficacy, driving bullish sentiment.
positive
+0.80
NewsDiscussionTradeModerna Generational Yolo Territory Part 2
r/wallstreetbets · May 18, 2026
The post highlights LUNG cancer as a key application for the new drug, alongside melanoma.
positive
+0.60
NewsDiscussionDDA new chapter to fight cancer ?
r/wallstreetbets · Feb 1, 2026
The post specifically references the reduction in lung metastases, a key outcome related to LUNG's research.
positive
+0.80
Page 1 of 6 (29 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.